Area of research
Cancer Research · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include NF-κB Signaling Pathways, Pituitary Gland Disorders and Treatments, Immune Response and Inflammation, and SARS-CoV-2 and COVID-19 Research.
Assessing Random Forest self-reproducibility for optimal short biomarker signature discovery
Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes
Outcome of publicly funded nationwide first-tier noninvasive prenatal screening
Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity
The <i>EGFRvIII</i> transcriptome in glioblastoma: A meta-omics analysis
Genomic Sequencing of SARS-CoV-2 in Rwanda: evolution and regional dynamics
A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay
A Phylodynamic Workflow to Rapidly Gain Insights into the Dispersal History and Dynamics of SARS-CoV-2 Lineages
Screening of germline mutations in young Rwandan patients with breast cancers.
Identification of a new VHL exon and complex splicing alterations in familial erythrocytosis or von Hippel-Lindau disease
Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients
X-linked acrogigantism syndrome: clinical profile and therapeutic responses
Connexin 30 expression inhibits growth of human malignant gliomas but protects them against radiation therapy